Clinical trial
Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
NCT00485680 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00485680 |
|---|---|
| Title | Olanzapine Versus Comparator in the Treatment of Bipolar Disorder |
| Official title | Olanzapine Versus Lithium Carbonate in the Treatment of Bipolar Disorder, Manic or Mixed Episodes |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine Hydrochloride, Lithium Carbonate |
| Enrollment | 140 |
| Start date | Dec 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Jun 13, 2007 |
| Last update posted | Jun 13, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: